WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006084041) NITROXIDES FOR USE IN TREATING OR PREVENTING DIABETES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/084041    International Application No.:    PCT/US2006/003696
Publication Date: 10.08.2006 International Filing Date: 02.02.2006
IPC:
A61K 31/445 (2006.01), A61K 31/47 (2006.01)
Applicants: MITOS PHARMACEUTICALS, INC. [US/US]; 3 San Joaquin Plaza, #200, Newport Beach, CA 92660 (US) (For All Designated States Except US).
HABASH, Louis [US/US]; (US) (For US Only).
JONES, Clarence [US/US]; (US) (For US Only)
Inventors: HABASH, Louis; (US).
JONES, Clarence; (US)
Agent: DELANEY, Karoline, A.; Knobbe, Martens, Olson & Bear, Llp, 2040 Main Street, 14th Floor, Irvine, CA 92614 (US)
Priority Data:
60/649,194 02.02.2005 US
Title (EN) NITROXIDES FOR USE IN TREATING OR PREVENTING DIABETES
(FR) NITROXYDES DESTINES A ETRE UTILISES DANS LE TRAITEMENT OU LA PREVENTION DE DIABETE
Abstract: front page image
(EN)Phamaceutical compositions are provided that are useful in treating diabetes. The compositions comprise a pharmaceutically acceptable carrier, and an effective therapeutic or prophylactic amount of a nitroxide antioxidant that alters the expression of genes related to diabetes. Methods are also provided for the use of the pharmaceutical compositions in the treatment or prevention of diabetes. In a preferred embodiment, the nitroxide antioxidant is Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl).
(FR)La présente invention a trait à des compositions pharmaceutiques qui sont utiles dans le traitement de diabète. Les compositions comportent un support pharmaceutiquement acceptable, et une quantité thérapeutique ou prophylactique d'un antioxydant à base de nitroxyde qui modifie l'expression de gènes associés au diabète. L'invention a également trait à des procédés pour l'utilisation des compositions pharmaceutiques dans le traitement ou la prévention de diabète. Dans un mode de réalisation préféré, l'antioxydant à base de nitroxyde est du Tempol (4-hydroxy-2,2,6,6-tétraméthylpipéridine-1-oxyle).
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)